Anoro Ellipta

Contains 2 active ingredients, Umeclidinium 62.5 mcg  and Vilanterol 25 mcg. These work in different ways to relax and open the airways and make it easier to breathe. In chronic obstructive lung diseases (COPD), such as chronic bronchitis or emphysema, the airways are narrowed and this makes breathing difficult.

Umeclidinium is a type of medicine known as an antimuscarinic or anticholinergic bronchodilator. It works in the lungs, where it blocks receptors called muscarinic receptors that are found on the muscle surrounding the airways. A natural body chemical called acetylcholine normally acts on these receptors, causing the muscle in the airways to contract and the airways to narrow.

Umeclidinium blocks the muscarinic receptors in the lungs and therefore stops the action of acetylcholine on them. This allows the muscle around the airways to relax and the airways to open. This makes it easier for people with COPD to breathe.

Vilanterol is a type of medicine called a long-acting beta 2 agonist or bronchodilator. It works by acting on receptors in the lungs called beta 2 receptors. When vilanterol stimulates these receptors it causes the muscles in the airways to relax, which allows the airways to open.

Inhaling these medicines allows them to act directly in the lungs where they are needed most. It also reduces the potential for side effects in other parts of the body, as the amount absorbed into the blood through the lungs is lower than if they were taken by mouth.

What is it used for?

Chronic obstructive pulmonary disease (COPD) in adults aged 18 years and over.

Anoro ellipta should not be used to relieve an attack of breathing difficulty. Instead, it should be used regularly each day to keep the airways open and help prevent breathing difficulties.

Size : 30 doses